雄激素阻断-话题@MedSci

#雄激素阻断#

44篇内容 | 888人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1641298, encodeId=43a0164129868, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=J Urol：雄激素阻断治疗是否会导致痴呆？, objectType=article, longId=293235, objectId=10d2293235fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10d2293235fd, replyNumber=0, likeNumber=36, createdTime=2022-09-05, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10d2293235fd, moduleTitle=J Urol：雄激素阻断治疗是否会导致痴呆？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10d2293235fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641296, encodeId=0fea164129619, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=Eur Urol：异时性转移激素敏感性前列腺癌男性中恩杂鲁胺和雄激素阻断疗法治疗的总生存率研究 , objectType=article, longId=212266, objectId=dc142122664a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc142122664a, replyNumber=0, likeNumber=33, createdTime=2021-07-20, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc142122664a, moduleTitle=Eur Urol：异时性转移激素敏感性前列腺癌男性中恩杂鲁胺和雄激素阻断疗法治疗的总生存率研究 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc142122664a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641293, encodeId=4573164129325, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=Cancer：前列腺癌患者接受雄激素阻断疗法的系统性炎症和症状学, objectType=article, longId=205536, objectId=0ec52055360c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ec52055360c, replyNumber=0, likeNumber=0, createdTime=2021-10-16, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ec52055360c, moduleTitle=Cancer：前列腺癌患者接受雄激素阻断疗法的系统性炎症和症状学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ec52055360c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641294, encodeId=e99b1641294da, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=JAMA Netw Open：恩扎鲁胺与比卡鲁胺联合雄激素阻断疗法对转移激素敏感型前列腺癌男性的临床疗效 , objectType=article, longId=206888, objectId=c9c720688846, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9c720688846, replyNumber=0, likeNumber=41, createdTime=2021-06-01, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9c720688846, moduleTitle=JAMA Netw Open：恩扎鲁胺与比卡鲁胺联合雄激素阻断疗法对转移激素敏感型前列腺癌男性的临床疗效 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9c720688846)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641295, encodeId=451b164129535, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=Eur Urol：雄激素受体剪接变异体7可预测接受雄激素阻断治疗转移激素敏感性前列腺癌患者的较短响应 , objectType=article, longId=208276, objectId=c5c32082e607, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5c32082e607, replyNumber=0, likeNumber=34, createdTime=2021-03-12, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5c32082e607, moduleTitle=Eur Urol：雄激素受体剪接变异体7可预测接受雄激素阻断治疗转移激素敏感性前列腺癌患者的较短响应 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5c32082e607)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641292, encodeId=7fed164129242, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=Eur Urol：有无放疗的雄激素阻断治疗原发性转移前列腺癌患者的生活质量, objectType=article, longId=202313, objectId=521b202313e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=521b202313e2, replyNumber=0, likeNumber=35, createdTime=2021-01-01, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=521b202313e2, moduleTitle=Eur Urol：有无放疗的雄激素阻断治疗原发性转移前列腺癌患者的生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=521b202313e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641297, encodeId=dfba164129ed0, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=Eur Urol Oncol：雄激素阻断疗法与多西他赛联用治疗高风险生化复发前列腺癌, objectType=article, longId=212395, objectId=fb5e21239575, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb5e21239575, replyNumber=0, likeNumber=40, createdTime=2021-11-18, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb5e21239575, moduleTitle=Eur Urol Oncol：雄激素阻断疗法与多西他赛联用治疗高风险生化复发前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb5e21239575)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641286, encodeId=28af164128685, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=Nat Commun：前列腺癌中雄激素阻断能够上调SPINK1的表达和增强细胞可塑性, objectType=article, longId=187073, objectId=c28718e07315, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c28718e07315, replyNumber=0, likeNumber=29, createdTime=2020-03-11, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c28718e07315, moduleTitle=Nat Commun：前列腺癌中雄激素阻断能够上调SPINK1的表达和增强细胞可塑性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c28718e07315)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641284, encodeId=57751641284a0, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=Prostate Cancer P D：雄激素阻断治疗前列腺癌后痴呆风险研究, objectType=article, longId=185239, objectId=4ae9185239b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ae9185239b6, replyNumber=0, likeNumber=25, createdTime=2020-05-14, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ae9185239b6, moduleTitle=Prostate Cancer P D：雄激素阻断治疗前列腺癌后痴呆风险研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ae9185239b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641288, encodeId=90ce1641288ca, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=Sci Rep：雄激素受体和聚（ADP-核糖）糖水解酶抑制剂能够增加前列腺细胞中雄激素阻断的效果 , objectType=article, longId=190411, objectId=10ab1904113e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10ab1904113e, replyNumber=0, likeNumber=27, createdTime=2020-09-21, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10ab1904113e, moduleTitle=Sci Rep：雄激素受体和聚（ADP-核糖）糖水解酶抑制剂能够增加前列腺细胞中雄激素阻断的效果 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10ab1904113e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641282, encodeId=5ef216412824d, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=Sci Rep：雄激素阻断治疗期间优先局部治疗和前列腺特异性抗原动力学对去势难治性前列腺癌生存的影响研究, objectType=article, longId=178499, objectId=25511e849963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25511e849963, replyNumber=0, likeNumber=29, createdTime=2020-05-29, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25511e849963, moduleTitle=Sci Rep：雄激素阻断治疗期间优先局部治疗和前列腺特异性抗原动力学对去势难治性前列腺癌生存的影响研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25511e849963)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641285, encodeId=a48f1641285d0, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=J Clin Oncol：局部前列腺癌中雄激素阻断治疗和外束放射治疗顺序研究, objectType=article, longId=185828, objectId=79fd185828b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79fd185828b2, replyNumber=0, likeNumber=38, createdTime=2020-04-02, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79fd185828b2, moduleTitle=J Clin Oncol：局部前列腺癌中雄激素阻断治疗和外束放射治疗顺序研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79fd185828b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641291, encodeId=fa7316412916c, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=J Clin Oncol：局部前列腺癌体外放射治疗中加入雄激素阻断治疗或者近距离放射治疗研究 , objectType=article, longId=195428, objectId=38a3195428ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38a3195428ae, replyNumber=0, likeNumber=39, createdTime=2020-11-14, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38a3195428ae, moduleTitle=J Clin Oncol：局部前列腺癌体外放射治疗中加入雄激素阻断治疗或者近距离放射治疗研究 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38a3195428ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641289, encodeId=3ab81641289c4, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=Nat Commun：前列腺特异性抗原动态能够预测个体对间歇性雄激素阻断治疗的个体响应 , objectType=article, longId=192841, objectId=60cc192841a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60cc192841a6, replyNumber=0, likeNumber=33, createdTime=2021-01-01, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60cc192841a6, moduleTitle=Nat Commun：前列腺特异性抗原动态能够预测个体对间歇性雄激素阻断治疗的个体响应 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60cc192841a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641290, encodeId=eafb16412909e, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=Eur Urol：恩杂鲁胺雄激素阻断治疗联用对转移激素敏感性前列腺癌患者健康相关生活质量影响研究, objectType=article, longId=193566, objectId=ed8f19356606, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed8f19356606, replyNumber=0, likeNumber=32, createdTime=2021-04-02, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed8f19356606, moduleTitle=Eur Urol：恩杂鲁胺雄激素阻断治疗联用对转移激素敏感性前列腺癌患者健康相关生活质量影响研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed8f19356606)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641287, encodeId=be0c164128ee9, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=J Clin Oncol：雄激素阻断治疗和外束放射治疗在局部前列腺癌中的治疗序列研究 , objectType=article, longId=190256, objectId=e5e81902560f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5e81902560f, replyNumber=0, likeNumber=27, createdTime=2021-02-05, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5e81902560f, moduleTitle=J Clin Oncol：雄激素阻断治疗和外束放射治疗在局部前列腺癌中的治疗序列研究 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5e81902560f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641281, encodeId=a2bb16412813d, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=Prostate：靶向POH1能够抑制前列腺癌细胞生长和增强雄激素阻断治疗以多烯紫杉醇的抑制效果, objectType=article, longId=174683, objectId=796a1e4683e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=796a1e4683e3, replyNumber=0, likeNumber=27, createdTime=2019-12-06, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=796a1e4683e3, moduleTitle=Prostate：靶向POH1能够抑制前列腺癌细胞生长和增强雄激素阻断治疗以多烯紫杉醇的抑制效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=796a1e4683e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641283, encodeId=e0771641283ac, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=Sci Rep：亚洲前列腺癌患者中周围血栓栓塞性血管疾病与雄激素阻断治疗相关性分析, objectType=article, longId=181660, objectId=b60318166080, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b60318166080, replyNumber=0, likeNumber=32, createdTime=2020-05-09, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b60318166080, moduleTitle=Sci Rep：亚洲前列腺癌患者中周围血栓栓塞性血管疾病与雄激素阻断治疗相关性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b60318166080)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641280, encodeId=1a2e1641280d7, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=Prostate Cancer P D：前列腺癌SLCO基因表达与格林森等级和雄激素阻断治疗后变化相关性分析, objectType=article, longId=163635, objectId=f0611636357e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0611636357e, replyNumber=0, likeNumber=34, createdTime=2019-05-11, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0611636357e, moduleTitle=Prostate Cancer P D：前列腺癌SLCO基因表达与格林森等级和雄激素阻断治疗后变化相关性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0611636357e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1641278, encodeId=3a4516412e8a8, content=<a href='/topic/show?id=469998e01fb' target=_blank style='color:#2F92EE;'>#雄激素阻断#</a>, objectTitle=J Clin Pharmacol：在前列腺癌患者中，雄激素阻断治疗能够增加心脏衰竭的风险, objectType=article, longId=154190, objectId=ce141541905c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce141541905c, replyNumber=0, likeNumber=32, createdTime=2019-07-21, rootId=0, userName=ms5106640509429053, userId=c62c22776697, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce141541905c, moduleTitle=J Clin Pharmacol：在前列腺癌患者中，雄激素阻断治疗能够增加心脏衰竭的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce141541905c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

雄激素阻断

2020-05-29

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

J Urol：雄激素阻断治疗是否会导致痴呆？

2022-09-05

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

Eur Urol：异时性转移激素敏感性前列腺癌男性中恩杂鲁胺和雄激素阻断疗法治疗的总生存率研究

2021-07-20

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

Cancer：前列腺癌患者接受雄激素阻断疗法的系统性炎症和症状学

2021-10-16

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

JAMA Netw Open：恩扎鲁胺与比卡鲁胺联合雄激素阻断疗法对转移激素敏感型前列腺癌男性的临床疗效

2021-06-01

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

Eur Urol：雄激素受体剪接变异体7可预测接受雄激素阻断治疗转移激素敏感性前列腺癌患者的较短响应

2021-03-12

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

Eur Urol：有无放疗的雄激素阻断治疗原发性转移前列腺癌患者的生活质量

2021-01-01

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

Eur Urol Oncol：雄激素阻断疗法与多西他赛联用治疗高风险生化复发前列腺癌

2021-11-18

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

Nat Commun：前列腺癌中雄激素阻断能够上调SPINK1的表达和增强细胞可塑性

2020-03-11

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

Prostate Cancer P D：雄激素阻断治疗前列腺癌后痴呆风险研究

2020-05-14

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

Sci Rep：雄激素受体和聚（ADP-核糖）糖水解酶抑制剂能够增加前列腺细胞中雄激素阻断的效果

2020-09-21

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

Sci Rep：雄激素阻断治疗期间优先局部治疗和前列腺特异性抗原动力学对去势难治性前列腺癌生存的影响研究

2020-05-29

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

J Clin Oncol：局部前列腺癌中雄激素阻断治疗和外束放射治疗顺序研究

2020-04-02

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

J Clin Oncol：局部前列腺癌体外放射治疗中加入雄激素阻断治疗或者近距离放射治疗研究

2020-11-14

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

Nat Commun：前列腺特异性抗原动态能够预测个体对间歇性雄激素阻断治疗的个体响应

2021-01-01

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

Eur Urol：恩杂鲁胺雄激素阻断治疗联用对转移激素敏感性前列腺癌患者健康相关生活质量影响研究

2021-04-02

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

J Clin Oncol：雄激素阻断治疗和外束放射治疗在局部前列腺癌中的治疗序列研究

2021-02-05

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

Prostate：靶向POH1能够抑制前列腺癌细胞生长和增强雄激素阻断治疗以多烯紫杉醇的抑制效果

2019-12-06

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

Sci Rep：亚洲前列腺癌患者中周围血栓栓塞性血管疾病与雄激素阻断治疗相关性分析

2020-05-09

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

Prostate Cancer P D：前列腺癌SLCO基因表达与格林森等级和雄激素阻断治疗后变化相关性分析

2019-05-11

ms5106640509429053 (审核中...)

前往app查看评论内容

#雄激素阻断#

J Clin Pharmacol：在前列腺癌患者中，雄激素阻断治疗能够增加心脏衰竭的风险

2019-07-21

科室
- - 订阅+
  - 更多科室
工具
服务